Matthew McPartlon

Matthew McPartlon is a seasoned technology leader and entrepreneur, recognized for his expertise in AI-driven drug discovery and protein interaction modeling. He is the Co-Founder and CTO of Chai Discovery, a biotech AI company that leverages advanced artificial intelligence to predict and reprogram biochemical interactions, significantly accelerating drug development timelines. With a strong background in biotechnology and AI, Matthew is dedicated to transforming the landscape of drug discovery through innovative technology.